Echo45 Advisors’s Thermo Fisher Scientific TMO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$215K Sell
428
-47
-10% -$22.6K 0.11% 72
2026
Q1
$234K Sell
475
-38
-7% -$20.6K 0.13% 66
2025
Q4
$297K Sell
513
-15
-3% -$8.48K 0.17% 54
2025
Q3
$256K Buy
528
+2
+0.4% +$931 0.15% 45
2025
Q2
$213K Sell
526
-30
-5% -$12.5K 0.13% 48
2025
Q1
$277K Sell
556
-17
-3% -$9.21K 0.19% 42
2024
Q4
$305K Buy
573
+33
+6% +$18.1K 0.2% 41
2024
Q3
$334K Sell
540
-22
-4% -$13K 0.22% 37
2024
Q2
$311K Sell
562
-63
-10% -$36.1K 0.22% 37
2024
Q1
$363K Hold
625
0.26% 32
2023
Q4
$332K Buy
625
+11
+2% +$5.32K 0.26% 31
2023
Q3
$311K Sell
614
-82
-12% -$43.7K 0.26% 29
2023
Q2
$363K Sell
696
-29
-4% -$15.6K 0.3% 25
2023
Q1
$418K Sell
725
-100
-12% -$56.4K 0.35% 23
2022
Q4
$454K Buy
825
+7
+0.9% +$3.71K 0.41% 24
2022
Q3
$415K Buy
818
+21
+3% +$11.8K 0.42% 23
2022
Q2
$433K Sell
797
-94
-11% -$51.7K 0.41% 24
2022
Q1
$526K Sell
891
-193
-18% -$111K 0.41% 33
2021
Q4
$723K Buy
+1,084
New +$677K 0.58% 32

Other funds holding TMO

Echo45 Advisors's TMO Position: Q2 2026 in Review

Echo45 Advisors reduced its Thermo Fisher Scientific (TMO) stake by 9.9% in Q2 2026, selling an estimated $22.6K and leaving 428 shares worth $215K. The position accounts for 0.11% of the portfolio, ranked #72.

Echo45 Advisors first reported a position in TMO in Q4 2021 and has held it in 19 quarters since. The position peaked at $723K in Q4 2021. 794 funds tracked by Wall St. Rank hold TMO as of Q2 2026.

  • Echo45 Advisors held 428 shares of Thermo Fisher Scientific worth $215K as of Q2 2026.
  • Echo45 Advisors sold 47 Thermo Fisher Scientific shares in Q2 2026, an estimated $22.6K.
  • Thermo Fisher Scientific made up 0.11% of Echo45 Advisors's portfolio in Q2 2026, its #72 holding.
  • Echo45 Advisors first reported a position in Thermo Fisher Scientific in Q4 2021 and has held it in 19 quarters since.
  • Echo45 Advisors's Thermo Fisher Scientific position peaked at $723K in Q4 2021.
  • 794 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2026.

Based on Echo45 Advisors's 13F filing for Q2 2026, filed 13 Jul 2026.